STOP-AMDR (Scaling the Optimal Use of Multiple ACTs to Prevent Antimalarial Drug Resistance) helps malaria-endemic countries stay ahead of drug resistance by diversifying treatment through multiple first-line therapies (MFTs). Supported by Unitaid and led by Jhpiego, STOP-AMDR brings together National Malaria Programmes, researchers, communities and global partners to translate MFT policy into practice, strengthen surveillance, generate evidence, address market barriers, and help preserve effective malaria treatments across Africa.
Promoting policy dialogue, evidence uptake, and stakeholder collaboration to create an enabling environment for MFT implementation and AMDR mitigation OR Strengthening collaboration among policymakers, health providers, reseachers, communities, civil society, and development partners to accelerate action against AMDR.